The genus broussonetia: A review of its phytochemistry and pharmacology

Phytotherapy Research

Volumn 26, Issue 1, 2012, Pages 1-10

  Wang, Guo Wei ^a   Huang, Bao Kang ^a   Qin, Lu Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Broussonetia; Moraceae; pharmacology; phytochemistry

Indexed keywords

ALKALOID; BROUSSOCHALCONE A; BROUSSOCHALCONE B; BROUSSOFLAVONOL C; BROUSSOFLAVONOL D; BROUSSOFLAVONOL E; BROUSSOFLAVONOL G; BROUSSOFLOURENONE A; BROUSSOFLOURENONE B; BROUSSONETIA KAZINOKI EXTRACT; BROUSSONETIA PAPYRIFERA EXTRACT; BROUSSONETIA ZEYLANICA EXTRACT; CHUSHIZISIN A; CHUSHIZISIN B; CHUSHIZISIN C; CHUSHIZISIN D; COUMARIN DERIVATIVE; DITERPENE; FLAVONOID; KAZINOL A; KAZINOL B; KAZINOL E; LIGNAN DERIVATIVE; PAPYRIFLAVONOL A; PLANT EXTRACT; PLANT GLYCOSIDE; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; TUPICHINOL C; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ANTIPLATELET ACTIVITY; ANTITYROSINASE ACTIVITY; BARK; BROUSSONETIA; BROUSSONETIA KAZINOKI; BROUSSONETIA PAPYRIFERA; BROUSSONETIA ZEYLANICA; CHINESE MEDICINE; DRUG ISOLATION; FLOWER; FRUIT; HUMAN; IC 50; IN VITRO STUDY; NONHUMAN; PAIN; PASSIVE SKIN ANAPHYLAXIS; PHYTOCHEMISTRY; PLANT GROWTH; PLANT LEAF; PLANT ROOT; REVIEW;

ANIMALS; BROUSSONETIA; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS;

BROUSSONETIA; MORACEAE;

EID: 84855708537     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3575     Document Type: Review

References (86)

1. Baek YS, Ryu YB, Curtislong MJ, et al,. 2009. Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki. Bioorg Med Chem 17: 35-41.
2. Byon JC, Kusari AB, Kusari J,. 1998. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol Cell Biochem 182: 101-108. (Pubitemid 28181653)
3. Cha JY, Kim YT, Kim HS, Cho YS,. 2008. Antihyperglycemic effect of stem bark powder from paper mulberry (Broussonetia kazinoki Sieb.) in type 2 diabetic Otsuka Long-Evans Tokushima fatty rats. J Med Food 11: 499-505.
4. Chang HW, Kudo I, Tomita M, Inoue K,. 1987. Purification and characterization of extracellular phospholipase A2 from peritoneal cavity of caseinate-treated rat. J Biochem 102: 147-154.
5. Chang SS, Chang CY, Cao ZY,. 1998. Moroideae. In Fl Reipubl Popularis Sin, Chang SS, Chang CY, (eds). Science Press: Beijing; 23: 1-219.
6. Chao JF, Yin ZQ, Ye WC, Zhao SX,. 2006. Chemical constituents from branch of Broussonetia papyrifera. Chin J Chin Mater Med 31: 1078-1080.
7. Chen RM, Hu LH, An TY, Li J, Shen Q,. 2002. Natural PTP1B inhibitors from Broussonetia papyrifera. Bioorg Med Chem Lett 12: 3387-3390. (Pubitemid 35292453)
8. Cheng Z, Lin C, Hwang T, Teng C,. 2001. Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem Pharmacol 61: 939-946. (Pubitemid 32247382)
9. D'Amelio FS, Mirhom Y,. 2000. Paper Mulberry and its Preparations as Tyrosinase Inhibitors and Skin Lightening Agents. Cosmetic Toiletries Manufacture Worldwide. Aston Publishing Group: Bushey Heath; 31-34.
10. Dehmlow EV, Sleegers A, Risch N, Trowitzsch-Kienast W, Wray V, Gunatilaka AAL,. 1990. Structure revision of a minor alkaloid from Broussonetia zeylanica. Phytochemistry 29: 3993-3995.
11. 2 superfamily of signal transduction enzymes. Trends Biochem Sci 22: 1-2. (Pubitemid 27056087)
12. Editorial Committee of Chinese Pharmacopoeia. 2010. Chinese Pharmacopoeia, 2010 edn. China Medical Science and Technology Press: Beijing, 315.
13. Fang SC, Shieh BJ, Lin CN,. 1994. Phenolic constituents of formosan Broussonetia papyrifera. Phytochemistry 37: 851-853.
14. Fang SC, Shieh BJ, Chang RR, Lin CN,. 1995. Isoprenylated flavonols of formosan Broussonetia papyrifera. Phytochemistry 38: 535-537.
15. Feng WS, Li HW, Zheng XK, Chen SQ,. 2007. Two new megastigmane O-glucopyranosides from the leaves of Broussonetia papyrifera. Chin Chem Lett 18: 1518-1520.
16. Feng WS, Li HW, Zheng XK, et al,. 2008. Chemical constituents from the leaves of Broussonetia papyrifera. Acta Pharm Sin 43: 173-180.
17. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW,. 1991. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 51: 718-723.
18. Floris AL, Peter LL, Reinier PA, Eloy HL, Guy ER, Chris W,. 2005. R-Glucosidase inhibitors for patients with type 2 diabetes: results from a cochrane systematic review and meta-analysis. Diabetes Care 28: 154-163.
19. Fukai T, Ikuta J, Nomura T,. 1986. Components of Broussonetia papyrifera (L.) Vent. III. Structures of two new isoprenylated flavonols, brossoflavonols C and D. Chem Pharm Bull 34: 1987-1993.
20. Fukai T, Nomura T,. 1989. Revised structures of brossoflavonols C and D, and the structures of brossoflavonol E. Heterocycles 29: 2379-2390.
21. Gunatilaka L, Uvais M, Sultanbawa S, Surendrakumar S, Somanathan R,. 1983. Structure of a bipyridine al kaloid from Broussonetia zeylanica. Phytochemistry 22: 2847-2850.
22. Gunatilaka AAL, Surendrakumar S, Thomson RH,. 1984. Broussonetine, a bisquinolyl-Iγ-butyrolactone from Broussonetia zeylanica. Phytochemistry 23: 929-931.
23. Ho HH, Lu JY,. 1997. A synopsis of the occurrence and pathogenicity of Phytophthora species in mainland China. Mycopathologia 138: 143-161. (Pubitemid 28073269)
24. Huang BK, Qin LP, Zheng HC, Zhang QY,. 2003. Analysis of amino acid and fatty acid of Fructus Broussonetiae. Acad J Sec Mil Med Univ 24: 213-217.
25. Hwang JH, Lee BM,. 2007. Inhibitory effects of plant extracts on tyrosinase, L-DOPA oxidation, and melanin synthesis. J Toxicol Environ Health A 70: 393-407. (Pubitemid 46522038)
26. Iida Y, Yonemura H, Oh KB, Saito M, Matsuoka H,. 1999. Sensitive screening of antifungal compounds from acetone extracts of medicinal plants with a Bio-Cell Tracer. Yakugaku Zasshi 119: 964-971.
27. Ikuta J, Hano Y, Nomura T,. 1985. Components of Broussonetia papyrifera (L.) Vent. 2. Structures of two new isoprenylated falvans, kazinols A and B. Heterocycles 23: 2835-2842.
28. Ikuta J, Hano Y, Nomura T, Kawakami Y, Sato T,. 1986. Components of Broussonetia kazinoki Sieb. 1. Structures of two new isoprenylated flavans and five new isoprenylated 1,3-diphenylpropane derivatives. Chem Pharm Bull 34: 1968-1979. (Pubitemid 16087537)
29. Jiangsu New Medical College. 1977. Dictionary of Chinese Materia Medica. Science and Technology Press of Shanghai: Shanghai, 2288-2289.
30. Jin JH, Hyun L, Kwon SY, Son KH, Kim HP,. 2010. Anti-inflammatory activity of the total flavonoid fraction from Broussonetia papyrifera in combination with Lonicera Japonica. Biomol Ther 18: 197-204.
31. Kato S, Hano Y, Fukai T, Kosuge Y, Nomura T,. 1986a. Kazinol P, a novel isoprenylated spiro-compound from Broussonetia kazinoki Sieb. Heterocycles 24: 2141-2145.
32. Kato S, Fukai T, Ikuta J, Nomura T,. 1986b. Components of Broussonetia kazinoki Sieb. (2). Structures of four new isoprenylated 1, 3-diphenylpropane derivatives, kazinols J, L, M, and N. Chem Pharm Bull 34: 2448-2455.
33. Kim SY, Kim JH, Kim SK, Oh MJ, Jung MY,. 1994. Antioxidant activities of selected oriental herb extracts. J Am Oil Chem Soc 71: 633-640.
34. Ko HH, Yu SM, Ko FN, Teng CM, Lin CN,. 1997. Bioactive constituents of Morus australis and Broussonetia papyrifera. J Nat Prod 60: 1008-1011.
35. Ko HH, Yen MH, Chang RR, Won SJ, Lin CN,. 1999. Cytotoxic isoprenylated flavans of Broussonetia kazinoki. J Nat Prod 62: 164-166.
36. Ko HH, Chang WL, Lu TM,. 2008. Antityrosinase and antioxidant Effects of ent-Kaurane Diterpenes from Leaves of Broussonetia papyrifera. J Nat Prod 71: 1930-1933.
37. Kwak WJ, Moon TC, Lin CX, et al,. 2003. Papyriflavonol A from Broussonetia papyrifera inhibits the passive cutaneous anaphylaxis reaction and has a secretory phospholipase A2-inhibitory activity. Biol Pharm Bull 26: 299-302. (Pubitemid 39663613)
38. Lee D, Bhat KP, Fong HH, Farnsworth NR, Pezzuto JM, Kinghorn AD,. 2001. Aromatase inhibitors from Broussonetia papyrifera. J Nat Prod 64: 1286-1293. (Pubitemid 33029208)
39. Lee D, Kinghorn AD,. 2003. Bioactive compounds from the genus Broussonetia. In Studies in Natural Products Chemistry., A.U. Rahman, (ed). Elsevier Science Publishers: Amsterdam, 28, 3-33.
40. Lee DY, Kim DH, Lee HJ, et al,. 2010. New estrogenic compounds isolated from Broussonetia kazinoki. Bioorg Med Chem Lett 20: 3764-3767.
41. Liewhiran C, Seraphin S, Phanichphant S,. 2006. Synthesis of nano-sized ZnO powders by thermal decomposition of zinc acetate using Broussonetia papyrifera (L.) Vent pulp as a dispersant. Curr Appl Phys 6: 499-502. (Pubitemid 43817779)
42. Lin CN, Chiu PH, Fang SC, Shieh BJ, Chang RR,. 1996a. Revised structure of broussoflavonol G and the 2D NMR spectra of some related prenylflavonoids. Phytochemistry 41: 1215-1217.
43. Lin CN, Lu CM, Lin HC, et al,. 1996b. Novel antiplatelet constituents from formosan moraceous plants. J Nat Prod 59: 834-838.
44. Lin LW, Chen HY, Chang CR, et al,. 2008. Comparison with various parts of Broussonetia papyrifera as to the antinociceptive and anti-inflammatory activities in rodents. Biosci Biotechnol Biochem 72: 2377-2384.
45. Macmicking J, Xie QW, Nathan C,. 1997. Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350. (Pubitemid 27169284)
46. Marrero MB, Fulton D, Stepp D, Stern DM,. 2004. Angiotensin II-induced insulin resistance and protein tyrosine phosphatases. Arterioscler Thromb Vasc Biol 24: 2009-2013. (Pubitemid 39482422)
47. Matsuda H, Cai H, Kubo M, Tosa H, Iinuma M,. 1995. Study on anticataract drugs from natural sources. II. Effects of buddlejae flos on in vitro aldose reductase activity. Biol Pharm Bull 18: 463-466.
48. Matsumoto J, Fujimoto T, Takino C, et al,. 1985. Components of Broussonetia papyrifera structures of two new isoprenylated flavonols and two chalcone derivatives. Chem Pharm Bull 33: 3250-3256. (Pubitemid 16221845)
49. Mei RQ, Wang YH, Du GH, Liu GM, Zhang L, Cheng YX,. 2009. Antioxidant lignans from the fruits of Broussonetia papyrifera. J Nat Prod 72: 621-625.
50. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I,. 1997. Regulatory functions of phospholipase A2. Crit Rev Immunol 17: 225-283.
51. Pang SQ, Huang BK, Zhang QY, Qin LP, Zheng HC,. 2006. Advances in research on chemical constituents of Broussonetiaplants and their pharmacological activities. Pharm Care Res 6: 98-102.
52. Pang SQ, Wang GQ, Huang BK, Zhang QY, Qin LP,. 2007. Isoquinoline alkaloids from Broussonetia papyrifera fruits. Chem Nat Compd 43: 100-102.
53. Pang SQ, Wang GQ, Huang BK, Qin LP,. 2009. Studies on chemical constituents of fructus broussonetiae. J Chin Med Mater 32: 1229-1231.
54. Parvez S, Kang M, Chung HS, Bae H,. 2007. Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries. Phytother Res 21: 805-816. (Pubitemid 47407639)
55. Ryu HW, Lee BW, Curtislong MJ, et al,. 2010. Polyphenols from Broussonetia papyrifera displaying potent α-glucosidase inhibition. J Agric Food Chem 58: 202-208.
56. Ryu JH, Ahn H, Lee HJ,. 2003. Inhibition of nitric oxide production on LPS-activated macrophages by kazinol B from Broussonetia kazinoki. Fitoterapia 74: 350-354. (Pubitemid 36623297)
57. Seiichiro O, Ayako M, Takashi O, Hideya Y, Hironobu H,. 2001. Synthesis and biological evaluation of R-L-fucosidase inhibitors: 5acarba-R-L- fucopyranosylamine and related compounds. Eur J Org Chem 5: 967-974.
58. Shibano M, Kitagawa S, Kusano G,. 1997a. Studies on the constituents of Broussonetia species. I. Two new pyrrolidine alkaloids, broussonetines C and D, as β-Galactosidase and β-Mannosidase inhibitors from Broussonetia kazinoki Sieb. Chem Pharm Bull 45: 505-508. (Pubitemid 27150214)
59. Shibano M, Kitagawa S, Nakamura S, Akazawa N, Kusano G,. 1997b. Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki Sieb. Chem Pharm Bull 45: 700-705. (Pubitemid 27209303)
60. Shibano M, Nakamura S, Akazawa N, Kusano G,. 1998a. Studies on the constituents of Broussonetia species. III. Two new pyrrolidine alkaloids, broussonetines G and H, as inhibitors of glycosidase, from Broussonetia kazinoki Sieb. Chem Pharm Bull 46: 1048-1050. (Pubitemid 28363337)
61. Shibano M, Nakamura S, Kubori M, Minoura K, Kusano G,. 1998b. Studies on the constituents of Broussonetia Species. IV. Two new pyrrolidinyl piperidine alkaloids, broussonetines I and J, from Broussonetia kazinoki Sieb. Chem Pharm Bull 46: 1416-1420. (Pubitemid 28455249)
62. Shibano M, Nakamura S, Motoya N, Kusano G,. 1999a. Studies on the constituents of Broussonetia Species. V. Two new pyrrolidine alkaloids, broussonetines K and L, as inhibitors of glycosidase, from Broussonetia kazinoki Sieb. Chem Pharm Bull 47: 472-476. (Pubitemid 29219997)
63. Shibano M, Tsukamoto D, Kusano G,. 1999b. A new pyrrolizidine alkaloid, broussonetine N, as an inhibitor of glycosidase, from Broussonetia kazinoki Sieb. and absolute stereostructures of broussonetines A and B. Chem Pharm Bull 47: 907-908. (Pubitemid 29315389)
64. Shibano M, Tsukamoto D, Fujimoto R, Masui Y, Sugimoto H, Kusano G,. 2000. Studies on the constituents of Broussonetia species. VII. Four new pyrrolidine alkaloids, broussonetines M, O, P, and Q, as inhibitors of glycosidase, from Broussonetia kazinoki Sieb. Chem Pharm Bull 48: 1281-1285.
65. Shibano M, Tsukamoto D, Inoue T, Takase Y, Kusano G,. 2001. The biosynthesis of broussonetines: origin of the carbon skeleton. Chem Pharm Bull 49: 504-506. (Pubitemid 32367692)
66. Shibata M, Ohkubo T, Takahashi H, Inoki R,. 1989. Modified formalin test: characteristic biphasic pain response. Pain 38: 347-352. (Pubitemid 19251258)
67. Sohn HY, Son KH, Kwon CS, Kwon GS, Kang SS,. 2004. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 11: 666-672. (Pubitemid 40007752)
68. Son KH, Kwon SJ, Chang HW, Kim HP, Kang SS,. 2001. Papyriflavonol A, a new prenylated flavonol from Broussonetia papyrifera. Fitoterapia 72: 456-458. (Pubitemid 32515313)
69. Takasugi M, Anetai M, Masamune T, Shirata A, Takahashi K,. 1980a. Broussonin A and B, new phytoalexins from diseased Paper Mulberry. Chem Lett 9: 339-340.
70. Takasugi M, Kumagai Y, Nagao S, Masamune T, Shirata A, Takahashi K,. 1980b. The co-occurrence of flavan and 1,3-diphenylpropane derivatives in wounded paper mulberry. Chem Lett 9: 1459-1460.
71. Takasugi M, Niino N, Anetai M, Masamune T, Shirata A, Takahashi K,. 1984a. Structure of two stress metabolites, spirobroussonin A and B, from diseased paper mulberry. Chem Lett 13: 693-694.
72. Takasugi M, Niino N, Nagao S, et al,. 1984b. Eight minor phytoalexins from diseased paper mulberry. Chem Lett 13: 689-692.
73. Tsai FH, Lien JC, Lin LW, Chen HY, Ching H, Chang CR,. 2009. Protective effect of Broussonetia papyrifera against hydrogen peroxide-induced oxidative stress in SH-SY5Y cells. Biosci Biotechnol Biochem 73: 1933-1939.
74. Tsukamoto D, Shibano M, Kusano G,. 2001a. Studies on the constituents of Broussonetia species X. Six new alkaloids from Broussonetia kazinoki Sieb. Chem Pharm Bull 49: 1487-1491. (Pubitemid 33043285)
75. Tsukamoto D, Shibano M, Okamoto R, Kusano G,. 2001b. Studies on the constituents of Broussonetia species VIII. Four new pyrrolidine alkaloids, broussonetines R, S, T, and V and a new pyrroline alkaloid, broussonetine U, from Broussonetia kazinoki Sieb. Chem Pharm Bull 49: 492-496. (Pubitemid 32367689)
76. Tsukamoto D, Shibano M, Kusano G,. 2003. Two new pyrrolidine alkaloids, broussonetines Y and Z from Broussonetia kazinoki Sieb. and activity of glycosidases inhibition by N-alkylation of broussonetines. J Nat Med 57: 68-72. (Pubitemid 36559910)
77. Vane JR, Mitchell JA, Appleton I, et al,. 1994. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 91: 2046-2050. (Pubitemid 24092039)
78. Wang JP, Tsao LT, Raung SL, Lin CN,. 1997. Investigation of the inhibitory effect of broussochalcone A on respiratory burst in neutrophils. Eur J Pharmacol 320: 201-208.
79. Wang JP, Tsao LT, Raung SL, Lin CN,. 1998. The signal transduction mechanism involved in kazinol B-stimulated superoxide anion generation in rat neutrophils. Br J Pharmacol 125: 517-525. (Pubitemid 28451490)
80. Yin ZQ, Chao JF, Zhang LH, Ye WC, Shen WB, Zhao SX,. 2006. Chemical constituents from Broussonetia papyrifera. Nat Prod Res Dev 18: 420-422.
81. Yuan X, Yuan P,. 2005. Analysis on chemical constituents and contents of oil from Broussonetia papyrifera fruits. J Plant Resour Environ 14: 54-55. (Pubitemid 40346305)
82. Zhang PC, Wang S, Chang Y, Chen RY, Yu DQ,. 2001a. Five new diprenylated flavonols from the leaves of Broussonetia kazinoki. J Nat Prod 64: 1206-1209. (Pubitemid 32937893)
83. Zhang PC, Wang S, Wang YH, Chen RY, Yu DQ,. 2001b. A new isoprenylated flavonol from the Leaves of Broussonetia kazinoki. Chin Chem Lett 12: 141-142.
84. Zheng HC, Hang BK, Qin LP, Zhang QY,. 2002. Biological character and resources distribution of Broussonetia. Chin Wild Plant Resour 21: 11-13.
85. Zheng ZP, Cheng KW, Chao J, Chang J, Wang M,. 2008. Tyrosinase inhibitors from paper mulberry (Broussonetia papyrifera). Food Chem 106: 529-535. (Pubitemid 47332864)
86. Zhou XJ, Mei RQ, Zhang L, et al,. 2010. Antioxidant phenolics from Broussonetia papyrifera fruits. J Asian Nat Prod Res 12: 399-406.